4.5 Article

Disappearing metabolic youthfulness in the cognitively impaired female brain

期刊

NEUROBIOLOGY OF AGING
卷 101, 期 -, 页码 224-229

出版社

ELSEVIER SCIENCE INC
DOI: 10.1016/j.neurobiolaging.2021.01.026

关键词

Alzheimer’ s disease; Mild cognitive impairment; Metabolic brain-age; Fluorodeoxyglucose; Positron emission tomography; Sex difference

资金

  1. Alzheimer's Society of Canada [13-32]
  2. Canadian Institute for Health Research [117121]
  3. Fonds de recherche du Quebec - Sante/Pfizer Canada - Pfizer-FRQS Innovation Fund [25262]
  4. National Institutes of Health [U01 AG024904]
  5. DOD ADNI (Department of Defense) [W81XWH-12-2-0012]
  6. National Institute on Aging
  7. National Institute of Biomedical Imaging and Bioengineering
  8. AbbVie
  9. Alzheimer's Association
  10. Alzheimer's Drug Discovery Foundation
  11. Araclon Biotech
  12. BioClinica, Inc.
  13. Biogen
  14. Bristol-Myers Squibb Company
  15. CereSpir, Inc.
  16. Cogstate
  17. Eisai Inc.
  18. Elan Pharmaceuticals, Inc.
  19. Eli Lilly and Company
  20. EuroImmun
  21. F. Hoffmann-La Roche Ltd
  22. Fujirebio
  23. GE Healthcare
  24. IXICO Ltd.
  25. Janssen Alzheimer Immunotherapy Research & Development, LLC.
  26. Johnson & Johnson Pharmaceutical Research & Development LLC.
  27. Lumosity
  28. Lundbeck
  29. Merck Co., Inc.
  30. Meso Scale Diagnostics, LLC.
  31. NeuroRx Research
  32. Neurotrack Technologies
  33. Novartis Pharmaceuticals Corporation
  34. Pfizer Inc.
  35. Piramal Imaging
  36. Servier
  37. Takeda Pharmaceutical Company
  38. Transition Therapeutics
  39. Canadian Institutes of Health Research
  40. European Commission [283562]
  41. National Institute On Aging of the National Institutes of Health [5R01AG03158119]
  42. Genentech, Inc.
  43. Fonds de recherche Quebec-Sante
  44. NSERC
  45. Canada Research Chairs Secretariat
  46. Universitede Sherbrooke Research Chair
  47. [P50 AG05681]
  48. [P01 AG03991]
  49. [R01 AG021910]
  50. [P50 MH071616]
  51. [U24 RR021382]
  52. [R01 MH56584]

向作者/读者索取更多资源

Sex differences play a significant role in brain metabolism among cognitively healthy individuals and those affected by cognitive impairment up to and including Alzheimer's disease. While healthy males exhibit older metabolic brain age compared to females, this distinction disappears in individuals with mild cognitive impairment and probable AD, suggesting a faster decline in brain glucose metabolism in females with cognitive impairment.
Sex differences play a vital role in human brain structure and physiology. Previous reports have proposed evidence hinting at a metabolic advantage in female brains across adulthood. It remained to be determined whether this advantage would be maintained across the spectrum of cognitive impairment, up to and including dementia due to Alzheimer's disease (AD). Here, using a machine-learning algorithm, we explore sex differences in metabolic brain-age derived from fluorodeoxyglucose positron emission tomography imaging among cognitively healthy individuals and those affected by mild cognitive impairment and clinically probable AD. First, we report that cognitively healthy male participants showed a persistently older looking brains when compared to healthy female participants in term of metabolic brain age, confirming earlier reports. However, this distinction disappeared among MCI individuals and probable AD patients, and this loss could not be explained by an accompanying neurodegeneration. This would seem to indicate that females have a higher rate of decline in brain glucose metabolism when cognitively impaired to negate their prior advantage. (c) 2021 Elsevier Inc. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据